APA (7th ed.) Citation

L, A., N, K., LS, H., R, V., DC, F., C, S., . . . C, O. (2024). BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytes. American journal of physiology. Cell physiology, 326(3), C880. https://doi.org/10.1152/ajpcell.00413.2023

Chicago Style (17th ed.) Citation

L, Alcober-Boquet, et al. "BI-3231, an Enzymatic Inhibitor of HSD17B13, Reduces Lipotoxic Effects Induced by Palmitic Acid in Murine and Human Hepatocytes." American Journal of Physiology. Cell Physiology 326, no. 3 (2024): C880. https://doi.org/10.1152/ajpcell.00413.2023.

MLA (9th ed.) Citation

L, Alcober-Boquet, et al. "BI-3231, an Enzymatic Inhibitor of HSD17B13, Reduces Lipotoxic Effects Induced by Palmitic Acid in Murine and Human Hepatocytes." American Journal of Physiology. Cell Physiology, vol. 326, no. 3, 2024, p. C880, https://doi.org/10.1152/ajpcell.00413.2023.